default-output-block.skip-main

News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs

NewsTrendsResourcesEventsOutsourcing-Pharma.comOpens in new window

Home
News
Trends
Resources
Events
Outsourcing-Pharma.comOpens in new window

Suppliers

UGA Biopharma

UGA Biopharma provides customised biosimilar and NBE development services, ready to use biosimilar cell banks and a high performance cell culture media (First CHOice® Medium).

Headlines

FDA approves first mesenchymal stromal cell therapy

Roche and Prothena’s Parkinson’s antibody treatment fails at phase 2

Teva and Sanofi’s IBD drug hits Phase 2 targets

Promotional features

An Experienced CDMO Can Be a Differentiator in the Rapidly Growing Biologics Market

Paid for and content provided by Scorpius BioManufacturing

Is GMP grade good enough? What mRNA manufacturers need to know when buying raw materials

Paid for and in partnership with Thermo Fisher Scientific - Biosciences

Continuous bioprocessing set to revolutionize cGMP manufacturing of biologics

Paid for and content provided by Just – Evotec Biologics

BioPharma-Reporter

Advertise with us
Apply to reuse our contentOpens in new window
Press Releases - Guidelines
About us
Contact us
Why Register?

Resources

Report a technical problem
Whitelist our newsletters
Help Centre
RSS Feed
Podcast
Archives